Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 2 |
2010 | 1 |
2011 | 2 |
2012 | 1 |
2014 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Development of an alginate-Matrigel hydrogel system to evaluate cancer cell behavior in the stiffness range of the bone marrow.
Front Biomater Sci. 2023;2:1140641. doi: 10.3389/fbiom.2023.1140641. Epub 2023 Jun 2.
Front Biomater Sci. 2023.
PMID: 38169992
Free PMC article.
Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells.
Dong Z, Meller J, Succop P, Wang J, Wikenheiser-Brokamp K, Starnes S, Lu S.
Dong Z, et al.
Int J Oncol. 2014 Sep;45(3):978-84. doi: 10.3892/ijo.2014.2486. Epub 2014 Jun 10.
Int J Oncol. 2014.
PMID: 24913497
Free PMC article.
Item in Clipboard
Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules.
Kupert E, Anderson M, Liu Y, Succop P, Levin L, Wang J, Wikenheiser-brokamp K, Chen P, Pinney SM, Macdonald T, Dong Z, Starnes S, Lu S.
Kupert E, et al.
BMC Cancer. 2011 Dec 9;11:513. doi: 10.1186/1471-2407-11-513.
BMC Cancer. 2011.
PMID: 22151235
Free PMC article.
Item in Clipboard
Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.
Oleksowicz L, Liu Y, Bracken RB, Gaitonde K, Burke B, Succop P, Levin L, Dong Z, Lu S.
Oleksowicz L, et al.
Prostate. 2012 Jul 1;72(10):1140-9. doi: 10.1002/pros.22463. Epub 2011 Nov 29.
Prostate. 2012.
PMID: 22127954
Free PMC article.
Item in Clipboard
Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer.
Dong Z, Liu Y, Scott KF, Levin L, Gaitonde K, Bracken RB, Burke B, Zhai QJ, Wang J, Oleksowicz L, Lu S.
Dong Z, et al.
Carcinogenesis. 2010 Nov;31(11):1948-55. doi: 10.1093/carcin/bgq188. Epub 2010 Sep 13.
Carcinogenesis. 2010.
PMID: 20837598
Free PMC article.
Item in Clipboard
Targeted overexpression of vav3 oncogene in prostatic epithelium induces nonbacterial prostatitis and prostate cancer.
Liu Y, Mo JQ, Hu Q, Boivin G, Levin L, Lu S, Yang D, Dong Z, Lu S.
Liu Y, et al.
Cancer Res. 2008 Aug 1;68(15):6396-406. doi: 10.1158/0008-5472.CAN-08-0645.
Cancer Res. 2008.
PMID: 18676865
Free PMC article.
Item in Clipboard
Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer.
Lee K, Liu Y, Mo JQ, Zhang J, Dong Z, Lu S.
Lee K, et al.
BMC Cancer. 2008 Jun 2;8:158. doi: 10.1186/1471-2407-8-158.
BMC Cancer. 2008.
PMID: 18518979
Free PMC article.
Item in Clipboard
Cite
Cite